Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Positive early data for lead mRNA COVID-19 vaccine candidate BNT-162b2

Aug. 21, 2020

Repurposing of low-cost generic nafamostat as COVID-19 therapy

Aug. 21, 2020

Ascletis completed bridging study of ASC-18 FDC pill for the treatment of hepatitis C

Aug. 21, 2020

First participant vaccinated in phase III study of MenABCWY meningitis vaccine candidate

Aug. 21, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical discovers HBV capsid assembly inhibitors

Aug. 21, 2020

Promising preclinical data for novel lymph node targeting COVID-19 vaccine

Aug. 21, 2020

Novel 3C-like protease inhibitors show efficacy in MERS-CoV-infected mice

Aug. 20, 2020

Efflux pump furthers antibiotic resistance, but via unexpected mechanism

Aug. 20, 2020

Update on development of PGX-YBG inhalable therapeutic for COVID-19

Aug. 19, 2020

Positive preclinical data presented for multi-target COVID-19 vaccine

Aug. 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...